Shanmuga Hospital Limited has issued a regulatory disclosure to BSE Limited regarding an upcoming board meeting. The meeting of the Board of Directors is scheduled to be held on Thursday, November 12, 2026.
The board will consider the following agenda items:
- Declaration of the unaudited financial results of the Company for the quarter and half year ended September 30, 2026
- Declaration of 1st interim dividend, if any, on the equity share capital of the Company for the Financial Year 2026-27
- Any other business with the permission of the Chair
Pursuant to SEBI (Prohibition of Insider Trading) Regulations, 2015 and the Company's Code of Conduct for Prevention of Insider Trading, the Trading Window for dealing in the securities of the Company has been closed with effect from October 1, 2026. The trading window will remain closed until 48 hours after the declaration of the unaudited financial results for the quarter and half year ended September 30, 2026.
The disclosure is made under Regulation 29(1)(a) of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015. The communication is signed by Kannan Anjana Maragatham, Company Secretary & Compliance Officer (Membership No. A70080).